Expression and significance of PTEN and nm23-H1 in the metastasis of non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 11, Issue 6, 2008, Pages 793-797

  Jiang, Zhijian ^a   Wang, Xiaoping ^b  

^a Chencun Hospital of Foshan City   (China)

^b First People's Hospital of Shaoguan   (China)

Author keywords

Immunohistochemistry; Lung neoplasms; Metastasis; nm23 H1; PTEN

Indexed keywords

NUCLEOSIDE DIPHOSPHATE KINASE A; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ARTICLE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION;

EID: 58549115058     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2008.06.05     Document Type: Article

References (17)

1. Toloza EM, Roth JA, Swisher SG. Molecular events in bronchogenic carcinoma and their implications for therapy. Semin Surg Oncol, 2000, 18(2): 91-99.
2. Ihde DC, Minna JD. Non-small cell lung cancer. Part I: Biology, diagnosis, and staging. Curr Probl Cancer, 1991, 15(2): 61-104.
3. Cairns P, Okami K, Halachmi S, et al. Frequent inactivation of PTEN/MMAC1 in primary prostatecancer. Cancer Res, 1997, 57(22): 4997-5000.
4. Yu J, Ni M, Xu J, et al. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer, 2002, 2(1): 29.
5. Frisk T, Foukakis T, Dwight T, et al. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer. Genes Chromosomes Cancer, 2002, 35(1): 74-80.
6. An Q, Liu Y, Gao Y, et al. Deletion of tumor suppressor genes in Chinese non-small cell lung cancer. Cancer Lett, 2002, 184(2): 189-195.
7. Zhu PC, Wu HM. The role of PTEN in the process of non-small cell lung cancer. J Huazhong Univ Sci Tech (Health Sci), 2003, 32(5): 463-466.
8. Steeg PS, Bevilacqua G, Kopper L, et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst, 1988, 80(3): 200-204.
9. Qian M, Feng Y, Xu L, et al. Expression of antimetastatic gene nm23-H1 in epithelial ovarian cancer. Chin Med J, 1997, 110(2): 142-144.
10. Gunduz M, Ayhan A, Gullu I, et al. Nm23 protein expression in larynx cancer and the relationship with metastasis. Eur J Cancer, 1997, 33(14): 2338-2341.
11. Guo X, Min HQ, Zeng MS, et al. Nm23-H1 expression in nasopharyngeal carcinoma: correlation with clinical outcome. Int J Cancer, 1998, 79(6): 596-600.
12. Iizuka N, Hirose K, Noma T, et al. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma. Br J Cancer, 1999, 81(3): 469-475.
13. Ohta Y, Nozaki Z, Nozawa H, et al. The predictive value of vascular endothelial growth factor and nm23 for the diagnosis of occult metastasis in non-small cell lung cancer. Jpn J Cancer Res, 2001, 92(3): 361-366.
14. Nie Q, Zhu W, Liu LX, et al. The mechanism and influence on the biological behavior of human high-metastatic large cell lung cancer cell lines with transfection of nm23-H1 gene. Chin J Lung Cancer, 2008, 11(3): 349-353.
15. Ma L, Zhou QH, Zhu W, et al. Effects of nm23-H1 point mutation on activity of GSK-3β in human high-metastatic large cell lung cancer cell line L9981. Chin J Lung Cancer, 2006, 9(1): 30-34.
16. Zhang WF, Yu L, Li Y, et al. Expression and significance of Pten/ MMCAI/Tep1 protein in lung adenocarcinoma and squamous cell carcinoma. J Chin Med Univ, 2007, 36(3): 336-337.
17. Goncharuk VN, del-Rosario A, Kren L, et al. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer. Ann Diagn Pathol, 2004, 8(1): 6-16.